TerminatedNCT04634669
Safety study of AXS-05 in Depression
This study was terminated in the United States. It is testing AXS-05 for Depression.
In United StatesDepressionDrugA study involving a medication or substance.Over 18 Years
Study directory
Back to overviewMental health studies with practical context.
Compare studies and check their requirements with the research team.
TerminatedNCT05030350
Safety study of PH94B in Social Anxiety Disorder (SAD)
This study was terminated in the United States. It focuses on anxiety.
In United StatesAnxietyDrugFrom 18 Years to 65 Years
CompletedNCT01875822
Study of Curcumin C-3 Complex in Schizophrenia
This study is completed in the United States. It is testing Curcumin C-3 Complex for schizophrenia.
Broader resultSchizophrenia, DepressionOtherFrom 18 Years to 65 Years
CompletedNCT00488319
Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
This study is completed in the United States, in Belgium, in Bulgaria, .... It focuses on schizophrenia.
In United StatesSchizophreniaDrugFrom 12 Years to 17 Years
CompletedNCT00237666
Study of Geodon in Non-Rapid Cycling Bipolar II people with Major Depression
This study is completed in the United States. It is testing geodon for depression.
In United StatesBipolarity, DepressionDrugOver 18 Years
CompletedNCT00088465
Study of Intramuscular Olanzapine Depot in people with Schizophrenia or Schizoaffective Disorder
This study is completed in the United States, in Australia, in France, .... It is testing intramuscular Olanzapine Depot for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 76 Years
WithdrawnNCT01932541
Latuda for Bipolarity
This study was withdrawn in the United States. It is testing latuda for Bipolarity.
In United StatesBipolarityDrugFrom 6 Years to 17 Years
CompletedNCT02357290
Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
This study is completed in the United States. It is testing N-Acetylcysteine for Bipolarity.
In United StatesBipolarityDrugFrom 5 Years to 17 Years
CompletedNCT04786990
Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD
This study is completed in the United States. It is testing SPN-812 Administered With Psychostimulants for ADHD.
In United StatesADHDDrugFrom 6 Years to 17 Years
TerminatedNCT02144155
Study of the Efficacy of Intranasal Oxytocin in Schizophrenia
This study was terminated in the United States. It is testing efficacy of Intranasal Oxytocin for schizophrenia.
In United StatesSchizophreniaDrugOver 18 Years
CompletedNCT00418262
Safety study of long Term Tolerability and Safety of Atomoxetine in ADHD
This study is completed in the United States. It is testing long Term Tolerability and Safety of Atomoxetine for ADHD.
In United StatesADHDDrugFrom 4 Years to 11 Years
CompletedNCT02219009
Usability of the Medical Information Device #1 System for schizophrenia
This study is completed in the United States. It is testing Usability of the Medical Information Device #1 System for schizophrenia.
In United StatesSchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.